Raghu Kalluri (University of Texas MD Anderson Cancer Center)

'Like a bul­let­proof vest': Can­cer cells make their own kind of col­la­gen. Can pierc­ing through make treat­ments bet­ter?

Sci­en­tists have long poked at tu­mor col­la­gen. In some cas­es, col­la­gen helped keep a tu­mor at bay. In oth­ers, it pro­tect­ed a tu­mor from T cells. One 2013 pa­per even de­scribed col­la­gen as a “dou­ble-edged sword” when it came to can­cer.

In a study pub­lished in Can­cer Cell to­day, Raghu Kalluri of the Uni­ver­si­ty of Texas MD An­der­son Can­cer Cen­ter and col­leagues il­lus­trate how pan­cre­at­ic can­cer cells make their own unique type of col­la­gen — one that not on­ly pro­tects them from the im­mune sys­tem, but al­so changes the very mi­cro­bio­me of the tu­mor it­self. By drug­ging this unique can­cer col­la­gen, sci­en­tists hope to im­prove the ef­fec­tive­ness of can­cer ther­a­pies such as check­point in­hibitors, which is es­pe­cial­ly im­por­tant for pan­cre­at­ic can­cers, where check­point in­hibitors have had mid­dling re­sults.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.